Primary ovarian insufficiency symptoms can be mild, but that does not necessarily mean your body is making enough ovarian hormones. When ovarian function declines before age 40, hormone therapy is generally recommended to replace hormones that would usually be present until menopause, often around age 50 or 51. The aim is not only to ease symptoms; it is also to support health during years of earlier-than-usual hormone loss.
Primary Ovarian Insufficiency Symptoms Can Be Mild
Primary ovarian insufficiency (POI) means the ovaries have reduced function before age 40. Periods may become irregular or stop, and symptoms can include hot flashes, night sweats, sleep disruption, vaginal dryness or discomfort during sex. Some people have few or manageable symptoms, but symptoms alone do not show whether estrogen levels are adequate or what the longer-term health effects may be.
POI is not always the same as permanent menopause: ovarian activity can sometimes return briefly, and pregnancy may still occur. If your periods change or you develop possible symptoms before 40, a clinician can assess whether POI or another cause is involved and discuss your health history and options.
Why Hormone Therapy Is Usually Recommended Until Menopause
In POI, hormone therapy (often called HRT in the UK and Australia, and HT or menopausal hormone therapy in the US) replaces estrogen and, where needed, other hormones earlier than expected. A 2024 evidence-based guideline developed by the ESHRE, ASRM, CRE-WHiRL and IMS POI Guideline Group recommends hormone therapy for people with POI until the usual age of menopause, unless an individual health factor makes it unsuitable. The guideline considered research published up to January 2024 and also notes that evidence for many POI treatment choices remains limited.
This recommendation is different from taking hormones solely to manage symptoms after menopause at the usual age. For someone with POI, treatment replaces hormones missing during years when they would commonly still be produced. If you feel well, that replacement rationale still matters; symptom relief is only one part of the decision. It does not mean hormone therapy is risk-free or right for everyone. Your medical history, including conditions that may make estrogen unsuitable, should shape the choice.
How This Differs From Starting Hormones Later
Findings about hormone therapy in older postmenopausal women are often mistakenly applied to younger people with POI. The groups are not interchangeable: their ages, timing of treatment and reasons for using hormones differ. Research on older women, including the Women’s Health Initiative trials, raised concerns about some outcomes with particular hormone regimens. Those findings are important, but they do not by themselves establish the balance of benefits and risks for hormone replacement in POI before 40.
That distinction is not a promise that risks disappear in younger people. It means the decision should be based on the specific situation—early hormone deficiency, personal health factors, the treatment formulation and how long it is used—rather than assuming evidence from later-life treatment answers the question for POI.
What Is Known About Bone and Heart Health
Estrogen helps maintain bone. POI is associated with lower bone mineral density and greater fracture risk; studies reviewed in POI literature report that hormone therapy can maintain or improve bone density. This supports replacing hormones during the years before the usual menopause age, but it does not guarantee that fractures will be prevented. Your clinician can consider your bone health and whether monitoring is appropriate for you.
POI is also associated with cardiovascular risk. Hormone therapy may help address some effects of early estrogen loss, but POI-specific evidence on long-term cardiovascular outcomes is less certain than the evidence on bone density. Treatment should not be described as a proven way to prevent heart disease. Cardiovascular health deserves individual attention alongside hormone decisions.
Choosing Treatment—and Remembering Contraception
Options vary by country and by individual. Estrogen may be given in different forms, and if you have a uterus, a progestogen is generally included to protect the uterine lining. The right formulation, dose and route depend on your health history and preferences; there is no single best HRT for POI that fits everyone. Discuss benefits, possible risks, follow-up and what to do as you approach the usual menopause age with a clinician familiar with POI.
Hormone therapy for POI is not contraception. Because ovarian activity can occasionally resume, pregnancy may still be possible. If avoiding pregnancy matters to you, ask about contraception separately; do not assume your hormone replacement provides it. Seek medical advice for possible POI or questions about treatment, especially if you have a personal health history that could affect hormone choices.